Home / Poster / Modeling the Binding Kinetics of Bispecific Antibodies under the Framework of a Minimal Human PBPK Model

Poster

Modeling the Binding Kinetics of Bispecific Antibodies under the Framework of a Minimal Human PBPK Model

Modeling the Binding Kinetics of Bispecific Antibodies under the Framework of a Minimal Human PBPK Model

Recommended for you

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

How Model-informed drug development rescue projects from a risky situation

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

© 2025 Certara. All Rights Reserved. | Privacy policy